non-inhibitory allosteric pharmacological chaperones (Gain Therapeutics)

N/A

Report date: 2025/06/11 11:07:04
NME

Base Information

Drug Namenon-inhibitory allosteric pharmacological chaperones (Gain Therapeutics)
Drug Alias NameGBA1 Program (Gain Therapeutics)glucosylceramidase allosteric chaperones (Gain Therapeutics)
ClassificationSmall molecules
Mechanisms of ActionNeuroprotectantsGlucosylceramidase modulators
TargetsGlucosylceramidase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGain Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesGain Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A